You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 10, October 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dementia

edited by John O'Brien, David Ames, and Alistair Burns, 2nd ed, 940 pp, 24 color plates, London, England, Arnold Publications, New York, NY, Oxford University Press Inc, 2000.

Arch Neurol. 2002;59:1659.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This multiauthored text examines all aspects of dementia. Different sections explore the history of dementia, the clinical diagnosis and assessment of dementia, including neuropsychologic testing and all of the current imaging modalities used around the world, to investigate patients with dementia. Particularly interesting are the sections on the multidisciplinary aspects of dementia management and the care-provider services available to persons with dementia. There are chapters devoted to the care-provider services of different parts of the world, including the United States, Great Britain, several other European nations, Japan, Australia, and the developing world. Chapters on the role of nursing and social work as well as legal issues and end-of-life decisions are all very clearly discussed.

The second major part of the book is devoted to Alzheimer disease, including the clinical aspects, risk factors, epidemiologic details, inflammatory mediators, and the neurobiologic characteristics of Alzheimer disease. The most recent research in this rapidly . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.